Aortic Stenosis
315
59
73
135
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
38 trials with published results (12%)
Research Maturity
135 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.4%
17 terminated out of 315 trials
88.8%
+2.3% vs benchmark
9%
28 trials in Phase 3/4
28%
38 of 135 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 135 completed trials
Clinical Trials (315)
The ShortCut™ Continued Access Study Protocol
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial
AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation
Derivation and Validation of the Aortic Valve Echocardiographic Calcium Score to Confirm Severe Aortic Stenosis: the Echo-AVCS Study
Evaluation of a Management Algorithm for TAVI Patients With Concomitant Mitral or Tricuspid Regurgitation
Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study)
Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
TRanscatheter Aortic-Valve Implantation Without On-site Cardiac Surgery
Cerebral Microembolization During Transcatheter Aortic Valve Implantation: Comparing Balloon-expandable and Self-expanding Valves
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Identifying Biological Markers of Cardiovascular Events in Patients With Aortic Stenosis or TAVI
Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease
Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedure
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
To Establish Whether Dapagliflozin and Spironolactone in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement, Result in Better Left Ventricular Mass Regression, Myocardial Health and Patient Reported Outcomes
Multicenter Study for the Validation of Willem AI: Aortic StenoSis Early Diagnosis With AI-electrocardiogram Study
Deep Learning-enhanced Personalized Monitoring of Aortic Stenosis - The DETECT-AS Prognostic Study
A Prospective, Multicenter, Observational Study Evaluating Safety and Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Replacement for Type-0 Bicuspid Aortic Valve Stenosis Patients in China
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)